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A long-term follow-up study of Lennox–Gastaut syndrome (LGS) (>10 years) was conducted with 38 patients with severe
motor and intellectual disabilities (SMID) to clarify the relationship between the rapid development of dysphagia and epileptic
seizures, and to elucidate the long-term evolution of LGS in patients with SMID.
Those who showed a relatively favourable seizure outcome were compared to those with a poor seizure outcome. Poor
seizure outcome correlated strongly with: (a) an early appearance of dysphagia and additional deterioration of the already
retarded mental function; (b) a predominance of atypical absence seizures; and (c) persistent frequent epileptiform discharges
during electroencephalographic evaluations.
Neither age at seizure onset nor intelligence level at the time of the last examination was correlated with seizure prognosis.
Further, seizure prognosis was not related to the aetiology of LGS. Repeated seizures apparently caused development of pro-
gressive epileptic encephalopathy, in addition to the underlying severe brain damage. Since development of dysphagia burdens
an already severely handicapped patient with intensive medical care, efforts to reduce the seizures and design a long-term care
plan are of great importance.
c© 2001 BEA Trading Ltd
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INTRODUCTION
Lennox–Gastaut syndrome (LGS) is an intractable
epileptic syndrome that is associated with the dete-
rioration of mental function. Previous studies on its
evolution have found that the mental deterioration is
self-limited and not progressive1–12.
However, we have observed that mental function
in a subgroup of LGS patients with severe motor
and intellectual disabilities (SMID) does not appear
to be self-limiting, but steadily deteriorates. Further-
more, patients in this supposed subgroup have shown
a rapid development of swallowing difficulty which
has not been described in previous reports. The aim
of the present study was to clarify the relationship be-
tween the rapid development of dysphagia and epilep-
tic seizures, and to elucidate the long-term evolution
of LGS in patients with SMID.
SUBJECTS AND METHODS
Patients
We investigated the long-term prognosis of LGS in (38
out of 548) all cases of SMID currently identified in
Shiga Prefecture, Japan (population 1 327 000, preva-
lence rate: 0.41/1000).
DainiBiwako-Gakuen Hospital is one of three hos-
pitals providing care for the severely handicapped in
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Shiga Prefecture. Between 1996 and 1999, our fa-
cility has given treatment to 1036 patients with a
variety of disabilities, including mental retardation,
motor impairment, muscular dystrophy, psychotic or
behavioural disorders, and epilepsy. Of these, 227
patients with SMID have been identified, while 127
(56%) of those also suffered from epilepsy.
Among the SMID patients of DainiBiwako-Gakuen
Hospital who had been followed up, those with LGS
were retrospectively reviewed. We defined patients as
having LGS who had been followed up for more than
10 years (from the first to the last EEG recording), and
who demonstrated either generalized tonic seizures or
more than two different types of generalized seizures
and also showed diffuse slow spike-wave activities in
the initial EEG recordings13–15.
Patients with known progressive degenerative dis-
orders were excluded from the study. The test sub-
jects comprised 38 patients (22 male and 16 female)
(Tables 1–3).
Table 2: Clinical data of 38 patients with Lennox–Gastaut
syndrome.
Clinical data n (%)
Sex male 22 (58%)
female 16 (42%)
Developmental age, yr <1 23 (61%)
1–2 9 (24%)
>2 6 (16%)
Motor impairment tetraplegia 14 (37%)
diplegia 15 (39%)
hemiplegia 4 (11%)
ataxia 5 (13%)
Age at seizure onset, yr <1 15 (39%)
1–5 12 (32%)
>5 11 (29%)
Aetiologic factor prenatal 9 (24%)
perinatal 7 (18%)
postnatal 5 (13%)
unknown 17 (45%)
Methods
To assess the intellectual levels of the patients, the
developmental ages (DAs) at the last EEG recording
were determined according to the Kyoto Scale of Psy-
chological Development16. The patients were classi-
fied by DA into three groups; 0–1 year, 1–2 years,
and >2 years. A favourable seizure outcome was de-
fined as a reduction of total seizure frequency to be-
low half of the initial frequency. Seizure prognoses
were favourable in 17 of the 38 (45%) patients. The
frequency in the remaining 21 (55%) patients was not
improved at the last EEG examination.
Table 3: Seizure types.
Seizure type At initial EEG At last EEG
recording recording
Tonic 36 (95%) 23 (61%)
Generalized tonic–clonic 25 (66%) 15 (39%)
Atypical absence 22 (58%) 13 (34%)
Myoclonic 10 (26%) 6 (16%)
Atonic 4 (11%) 3 (8%)
Partial 0 (0%) 4 (11%)
Seizure free 0 (0%) 10 (26%)
Improvement of abnormalities observed in EEG was
defined by either a reduction in the frequency of
epileptic discharges recorded during sleep stage 1–2
to below half and/or the appearance of focal epilepti-
form discharges instead of generalized ones. Dyspha-
gia was defined as the presence of swallowing diffi-
culties and/or having had more than two episodes of
aspiration pneumonia.
The intellectual disabilities of patients in the cur-
rent series were so severe that changes in intellectual
functions could not be evaluated by routine psychome-
tric test procedures. Accordingly, we determined that
a progression of mental deterioration was present only
when both a psychologist and the attending physician
judged independently that at least one of the follow-
ing conditions had emerged: (a) a decreased frequency
of hand reaching and grasping behaviour; (b) a dra-
matic reduction of gesturing or verbal communication
behaviour; (c) a regression of visual cognitive abil-
ity, as represented by the disappearance of following
movement with the eyes and/or inability to identify
or distinguish the shape of objects; and (d) a com-
plete disappearance of meaningful vocalization. Most
patients had been submitted for polytherapy, in which
valproate was used predominately in combination with
other antiepileptic drugs. The doses and types of pre-
scribed antiepileptic drugs being taken at the last ex-
amination did not differ between the favourable and
unfavourable seizure outcome groups.
For statistical calculations, a chi-squared test was
employed. A P value of less than 0.05 was considered
statistically significant.
Table 4: Characteristics of severely disabled patients with
and without favourable seizure outcomes.
Characteristics Favourable Unfavourable P Value
outcome outcome
(n = 17) (n = 21)
Active EEG discharges, n (%) 1 (3) 14 (37) P < 0.001
Atypical absence seizure, n (%) 6 (16) 16 (42) P < 0.03
Mental deterioration, n (%) 0 (0) 11 (29) P < 0.003
Progression of dysphagia, n (%) 1 (3) 14 (37) P < 0.001
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RESULTS
Neurological findings
Progression of mental deterioration during the ob-
served periods was noted in 11 of the 38 (29%)
patients. Fifteen (39%) presented an early appear-
ance of swallowing difficulty, and many of them re-
quired tube feeding. Progression of mental deteriora-
tion and an early appearance of dysphagia were both
more common in patients who continued to have ac-
tive epilepsy (P < 0.003 and P < 0.001, respectively).
EEG
Frequent epileptiform discharges seen by EEG per-
sisted in 15 (39%) patients and a poor seizure outcome
was found to have a close correlation with this contin-
uation of frequent epileptiform discharges (P < 0.001)
(Table 4).
Seizures
Twenty-two (58%) patients exhibited atypical absence
seizures at the initial EEG recording. The proportion
of patients with a poor seizure outcome was higher
in those with absence seizures than in those with-
out (P < 0.03). A similar correlation of atypical ab-
sence seizures was noted with progressive mental re-
gression (P < 0.03), but not with swallowing difficulty
(Table 4).
Others
Developmental age did not differ in patients with a
favourable outcome as compared to those with un-
favourable prognoses, nor did the ages at seizure on-
set differ among the patients with favourable and un-
favourable outcomes. Further, there was no significant
difference between the seizure outcome groups with
regard to causes of illness.
DISCUSSION
According to the population studies2, 17, the occur-
rence of LGS is 0.24–0.28/1000 live births. The an-
nual incidence of LGS in a community-based study
in Southern Finland was 2/100 000 (children aged
0–14 years)18. In contrast to this rather low inci-
dence in the general population, LGS has proven to be
over-represented in mentally retarded persons. Mari-
ani et al.19 analysed 1023 institutionalized patients,
and found that 326 were diagnosed with epilepsy, with
53 (16%) of those having LGS. In a community-based
study, Steffenburg et al.20 found that LGS constituted
3% (3 out of 98) of the patients with both epilepsy and
developmental delay. This incidence was well in ac-
cordance with the results reported by Forsgren et al.21,
who found LGS in 4.2% of children and adults with
both mental retardation and epilepsy. In contrast, in the
present study the incidence of LGS amounted to 30%
(38 out of 127) in patients with SMID and epilepsy.
The incidence of unfavourable seizure prognosis in
patients with LGS in the present study was fairly con-
sistent with that reported in many previous studies. In
a study by Roger et al.3, which followed 338 chil-
dren with LGS until adulthood, 62.4% of the patients
had an unfavourable outcome, whereas 37.6% had a
more or less favourable outcome. A long-term follow-
up study of 89 patients with LGS by Ohtsuka et al.7
confirmed seizure persistence in 68 (76.4%). Further-
more, Ignatowicz et al.22 reported that improvement
was achieved in about 30% of 92 treated children with
LGS, whereas the prognosis of the remaining 70% was
poor. Paradoxically, the proportion of patients with a
favourable seizure prognosis and SMID (45%) was
higher in the current study than in these previous stud-
ies. Although this discrepancy is difficult to interpret
because of the different criteria used for favourable
and unfavourable seizure prognosis, the frequency of
seizures might be reduced in institutionalized patients
with LGS after adolescence, as Rai et al.23 have sug-
gested.
As for seizure types, Yagi et al.10 observed 102
patients with LGS for an average of 16 years and found
that clinico-electroencephalographic findings charac-
teristic of LGS continued in one third, while seizures
in the other two thirds decreased in frequency as well
as number of types. Oguni et al.11 reported that char-
acteristic LGS features disappeared with age in 33%
of patients with cryptogenic LGS and 55% with symp-
tomatic LGS, while drop attacks and gait deterioration
were so disabling in the daily life of some patients
that they eventually became wheelchair bound. Beau-
manoir2 reported that 48 of 103 patients (47%) re-
tained LGS characteristics after 10 years of follow-up.
In a study by Yagi et al.10, during follow-up no
patient with LGS was found to have only partial
seizures. However, Oguni et al.11 reported that several
LGS cases evolved to focal epilepsy, and Roger et al.3
also stressed that, in 15.6% of their cases, initial LGS
disappeared and focal types of epilepsy with multiple
foci appeared instead. Further, Bauer et al.5 noted that
some patients with a long history of LGS since child-
hood later developed focal temporal lobe epilepsy.
Moreover, we found that a subgroup of patients with
LGS developed partial seizures later in the course of
illness, which simulated those with frontal lobe origin.
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Most investigators agree that a preceding history
of West syndrome is a predictor of poor progno-
sis7, 17, 22, 24. Other unfavourable factors include early
onset, a history of infectious disease at epilepsy on-
set, delayed developmental milestones prior to the on-
set of epilepsy, abnormalities in neurological or neuro-
radiological examinations, a progressive deterioration
of the general condition, the presence of focal signs,
the presence of status epilepticus and tonic seizures,
multiple seizure types, abnormalities during gestation
or the perinatal period, and a delayed initiation of
the therapeutic approach3, 18, 20, 22, 25. However, in the
patients with SMID examined in the current study, age
at onset of epilepsy, degree of mental retardation, and
causes of the illness did not predict seizure progno-
sis. We conclude that these factors are less significant
when study subjects are restricted to patients with se-
vere brain damage that leads to SMID. Instead, per-
sistent active EEG abnormalities proved to be a poor
prognostic factor for seizure outcome5, 7, 10, 19, 27.
Patients with LGS show some deterioration of psy-
chomotor function with age1, 3, 7, 10–12, 20, 26, 27. A sig-
nificant decrease in IQ score over time is common.
Kurokawa et al.1 reported that, among handicapped
children, frequent attacks and marked deterioration of
mental function offered the most serious problems for
daily care at home or in institutions.
From our study, a persistence of active seizures was
demonstrated to have a close association with both
progression of mental deterioration (n = 11, 29%)
and rapid regression in swallowing abilities (n = 14,
37%). This suggests that repeated seizures might urge
progression of the epileptic encephalopathies, in addi-
tion to the pre-existent severe brain damage, leading
to additional regression in motor and intellectual func-
tion28.
Several previous studies7, 26 have suggested that
later development of mental function deficits depend
upon the types of persistent seizures, especially the
presence of minor motor seizures. Lesser et al.29 con-
tradicted this and asserted that the severity of seizures,
but not the type, was more closely associated with
progressive regression of intellectual function. The
present study, in agreement with Doose and Vo¨lke30,
revealed that the presence of atypical absence seizures
at the initial EEG recording was a potent predictor
of seizure intractability and mental regression. This
might be partially explained by the fluctuating impair-
ment of consciousness and reduced cognitive activities
during absence seizures, which may occasionally con-
tinue throughout the day.
We confirmed that a subgroup of patients with LGS,
especially those with unchanged active seizure activ-
ity, showed rapid development of dysphagia, without
evidence of other plausible causative factors result-
ing in difficulties with swallowing. We conclude that
the feeding disturbance, along with mental regression,
was caused by the persistent epileptic activity itself.
Therefore, swallowing difficulty may be regarded as
an important sign of the progression of epileptic en-
cephalopathy. The dysphagia leads to intensive medi-
cal care and forces many patients with LGS to receive
tube feeding. Furthermore, as aspiration pneumonia is
one of the main causes of death in patients with SMID,
the significance of our finding is all the more appar-
ent. Our study suggests that extensive efforts towards
reducing seizure frequency are very important even
in patients with SMID, as they could prevent further
quality of life deterioration in these patients who are
already severely handicapped.
REFERENCES
1. Kurokawa, T., Goya, N., Fukuyama, Y., Suzuki, M., Seki,
T. and Ohtahara, S. West syndrome and Lennox–Gastaut syn-
drome: a survey of natural history. Paediatrics 1980; 65:
81–88.
2. Beaumanoir, A. The Lennox–Gastaut syndrome: a personal
study. Electroencephalography and Clinical Neurophysiology
1982; (Suppl. 35): 85–89.
3. Roger, J., Remy, C., Bureau, M. et al. Lennox–Gastaut syn-
drome in the adult. Revue Neurologique (Paris) 1987; 143:
401–405.
4. Todt, H. and Eysold, R. Long-term observations. In: The
Lennox–Gastaut Syndrome (Eds E. Niedermeyer and R. De-
gen). New York, Alan R. Liss, 1988: pp. 377–386.
5. Bauer, G., Benke, T. and Bohr, K. The Lennox–Gastaut syn-
drome in adulthood. In: The Lennox–Gastaut Syndrome (Eds
E. Niedermeyer and R. Degen). New York, Alan R. Liss, 1988:
pp. 317–327.
6. Furune, S., Watanabe, K., Negoro, T. et al. Long-term progno-
sis and clinico-electroencephalographic evolution of Lennox–
Gastaut syndrome. Brain Dysfunction 1988; 1: 146–153.
7. Ohtsuka, Y., Amano, R., Mizukawa, M. and Ohtahara,
S. Long-term prognosis of the Lennox–Gastaut syndrome.
Japanese Journal of Psychiatry and Neurology 1990; 44:
257–264.
8. Yagi, K. and Seino, M. Lennox–Gastaut syndrome: clinical
seizure outcome and social prognosis. Japanese Journal of
Psychiatry and Neurology 1990; 44: 374–375.
9. Dulac, O. and N’Guyen, T. The Lennox–Gastaut syndrome.
Epilepsia 1993; 34 (Suppl. 47): S7–17.
10. Yagi, K. Evolution of Lennox–Gastaut syndrome: a long-
term longitudinal study. Epilepsia 1996; 37 (Suppl. 3): 48–51.
11. Oguni, H., Hayashi, K. and Osawa, M. Long-term prognosis
of Lennox–Gastaut syndrome. Epilepsia 1996; 37 (Suppl. 3):
44–47.
12. Wheless, J. M. and Constantinou, J. E. Lennox–Gastaut syn-
drome. Paediatric Neurology 1997; 17: 203–211.
13. Ohtahara, S., Ohtsuka, Y. and Kobayashi, K. Lennox–Gastaut
syndrome: a new vista. Psychiatry and Clinical Neurosciences
1995; 49: S179–183.
14. Ohtahara, S. Lennox–Gastaut syndrome: considerations in its
concept and categorization. Japanese Journal of Psychiatry
and Neurology 1988; 42: 535–542.
15. Commission on Classification and Terminology of the Interna-
tional League Against Epilepsy. Proposal for revised classifi-
cation and epileptic syndromes. Epilepsia 1989; 30: 389–399.
16. Kyoto Scale of Psychological Development: Assessment and
Applications. 2nd Edition (Eds H. Shimazu, M. Ikusawa,
Y. Matsushita and A. Nakase). Kyoto, Nakanishiya, 1989.
202 K. Ogawa et al.
17. Rantala, H. and Putkonen, T. Occurrence, outcome, and prog-
nostic factors of infantile spasms and Lennox–Gastaut syn-
drome. Epilepsia 1999; 40: 286–289.
18. Heiskala, H. Community-based study of Lennox–Gastaut syn-
drome. Epilepsia 1997; 38: 526–531.
19. Mariani, E., Ferini-Strambi, L., Sala, M., Erminio, C. and
Smirne, S. Epilepsy in institutionalized patients with en-
cephalopathy: clinical aspects and nosological considerations.
American Journal of Mental Retardation 1993; 9 (Suppl. 98):
27–33.
20. Steffenburg, U., Hedstrom, A., Lindroth, A., Wiklund, L. M.,
Hagberg, G. and Kyllerman, M. Intractable epilepsy in a
population-based series of mentally retarded children. Epilep-
sia 1988; 39: 767–775.
21. Forsgren, L., Edvinsson, S. O., Blomguist, H., Heijbel, J. and
Sidenvall, R. Epilepsy in a population of mentally retarded
children and adults. Epilepsy Research 1990; 6: 234–248.
22. Ignatowicz, R., Michalowicz, R., Iganotowiczowa, L. and
Kmiec, T. Lennox–Gastaut syndrome: clinical course and ther-
apy. Polski Tygodnik Lekarski 1994; 49: 96–98.
23. Rai, P. V., Fu¨lo¨p, T. and Erc¸al, S. Clinical course of Lennox–
Gastaut syndrome in institutionalized adult patients. In: The
Lennox–Gastaut Syndrome (Eds E. Niedermeyer and R. De-
gen). New York, Alan R. Liss, 1988: pp. 409–418.
24. Ohtsuka, Y., Ogino, T., Murakami, N., Mikami, N., Kobayashi,
K. and Ohtahara, S. Developmental aspects of epilepsy with
special reference to age-dependent epileptic encephalopathy.
Japanese Journal of Psychiatry and Neurology 1986; 40:
307–313.
25. Berg, A., Levy, S. R., Edward, J. N. and Shinnar, S. Predic-
tors of intractable epilepsy in childhood: a case control study.
Epilepsia 1996; 37: 24–30.
26. Froscher, W. and Neher, K. D. Psychiatric changes caused by
epileptic seizures. Schweizer Archiv fur Neurologie und Psy-
chiatrie 1994; 145: 4–7.
27. Kurokawa, T. Clinical and EEG findings and prognosis of
seizure disorders in children. Epilepsia 1996; 37 (Suppl. 3):
2–4.
28. Bullen, J. Cognitive function and epilepsy. In: Epilepsy in
Young People (Eds E. Ross, D. Chadwick and R. Crawford).
Chichester, John Wiley & Sons, 1987: pp. 73–80.
29. Lesser, R. P., Luders, H., Wyllie, E., Dinner, D. S. and Morris,
H. H. 3rd. Mental deterioration in epilepsy. Epilepsia 1986; 27
(Suppl. 2): S105–123.
30. Doose, H. and Vo¨lke, E. Petit mal-status in early childhood
and dementia. Neuropaediatrie 1979; 10: 10–14.
